Skip to main content

Table 1 Baseline characteristic of the study cohort. Median and interquartile range (IQR: 25%-75%) or mean ± SD are reported for continuous variables. Simple frequencies (n) and percentages are reported for categorical variables. Abbreviations: BMIa, Body mass Index; HRb, Heart Rate; HDLc, High Density Lipoprotein; PLWHd, People living with HIV; NAe, not applicable

From: Unexpected increase of myocardial extracellular volume fraction in low cardiovascular risk HIV patients

Parameters HIV-infected
(n=53)
Control group
(n=18)
p-value
General characteristics
 Male, n (%) 45 (85) 14 (77) 0.129
 Age, Years 48 (42.5-48) 55 (44.5-56) 0.122
 BMIa, kg/m2 22 (20.3-22) 27 (24–32) 0.116
 HRb, bpm 67 (±9.1) 65 (±11.3) 0.211
 Systolic blood pressure, mmHg 119 (±10) 114 (±11) 0.131
 Diastolic blood pressure, mmHg 75 (±9) 67 (±6) 0.061
Laboratory results
 Total cholesterol, (mg/dl) 189 (177-189) 188 (154–201) 0.557
 HDLc, (mg/dl) 39 (35-39) 54 (46–66) 0.046
 Triglycerides, (mg/dl) 101 (78-170) 124 (80–177) 0.077
Other factors
 Diabetes, n (%) 0 (0) 0 (0) 1.000
 Smoking, n (%) 9 (17) 4 (22) 0.686
 Framingham Risk (%) 4 (1-6.5) 3 (1-5) 0.182
 ASCVD 10 years, calculated risk 4.6 (2.7-4.6) 4.6 (1.7-3.5) 0.286
Immune-virologic status
 Years of therapy, Years 9 (6-9) - NAa
 Years of exposure to HIV infection, Years 10 (1-23) - NAa
 CD4 enrolment (cell/μl) 450 (328-750) - NAa
 CD4 nadir (cell/μl) 181 (94-300) - NAa
 % of PLWHe naïve for cART 12.7 - NAa
 HIV-RNA copies/ml in cART treated PLWH <37 - NAa
 HIV-RNA copies/ml in cART naive PLWH 55.000 - NAa